The only centre under GNCTD performing Liver and Kidney transplants.

Liver Cancer Treatment

Liver Cancer Treatment

What is hepatocellular carcinoma?

Liver cancer or hepatocellular carcinoma (HCC) is among of the common malignant tumours in the world, with a global increasing annual incidence, as reported recently. Almost half of this increase has been attributed to hepatitis C virus (HCV), while a minimal or no increase has been related to hepatitis B virus (HBV) or alcoholic liver disease. Untreated HCC has a notoriously poor prognosis, with a median survival of one to eight months and a five year survival of around 3%.

What are the treatment options for liver cancer?

Potentially curative surgical therapeutic options:

  • Partial hepatic resection of HCC with adequate margins
  • Liver transplantation for HCC

(However, only 30% to 40% of patients with HCC qualify for surgery, mostly due to advanced disease at presentation and poor hepatic function, rendering the majority of patients eligible only for palliation)

Non-surgical palliative treatment options:

 
  • ECHO
  • ECHO
  • APASL
  • Acuteon
  • DORSO
  • NSI
  • HBSCE
  • NLDB

Copyright © Institute of Liver & Biliary Sciences 2016. All rights reserved. Designed & Developed by Cyfuture